Tag Archives: DEA

Federal appeals court hears hemp industry lawsuit challenging DEA’s position on CBD

Published: Feb 15, 2018, 5:24 pm • Updated: Feb 15, 2018, 5:33 pm By Alicia Wallace, The Cannabist Staff The fate of a federal rule viewed by hemp advocates as an existential threat to their emerging industry is now in

Trial begins for advocates suing Sessions and the DEA over marijuana’s Schedule I status

Published: Feb 14, 2018, 11:03 am • Updated: Feb 14, 2018, 3:07 pm By Karen Matthews, The Associated Press NEW YORK (AP) — Army veteran Jose Belen says the horrors of the Iraq War left him with post-traumatic stress disorder,

Hemp industry lawsuit challenging DEA’s position on CBD picks up support of 28 U.S. legislators

Published: Jan 12, 2018, 4:29 pm • Updated: Jan 12, 2018, 4:29 pm By Alicia Wallace, The Cannabist Staff A bipartisan congressional coalition pushed back on the U.S. Drug Enforcement Administration’s assertion that cannabidiol and extracts derived from hemp are

World Health Organization: Initial review of CBD doesn’t warrant scheduling

Published: Dec 13, 2017, 10:08 am • Updated: Dec 13, 2017, 11:26 am By Alicia Wallace, The Cannabist Staff CBD, for now, should not be subject to international drug scheduling, a World Health Organization committee determined in an initial review

DEA finalizing Schedule II status for synthetic THC drug Syndros

Published: Nov 21, 2017, 8:50 am • Updated: Nov 21, 2017, 9:36 am By Alicia Wallace, The Cannabist Staff The U.S. Drug Enforcement Administration this week will grant Schedule II status to a synthetic THC drug developed by a pharmaceutical

DEA finalizes quota of government-grown marijuana for 2018 research: 978 pounds

Published: Nov 7, 2017, 4:59 pm • Updated: Nov 7, 2017, 4:59 pm By Alicia Wallace, The Cannabist Staff The U.S. Drug Enforcement Administration this week will formalize its production quotas of drugs and substances utilized for medical, scientific and

Jeff Sessions calls for “more competition” among medical marijuana growers for research

Published: Oct 18, 2017, 9:45 am • Updated: Oct 18, 2017, 10:12 am By Polly Washburn, The Cannabist Staff In testimony before the Senate Judiciary Committee on Wednesday morning, U.S. Attorney General Jeff Sessions said there should be “more competition”

How Congress helped drug company lobbyists derail the DEA’s war on opioids

Published: Oct 16, 2017, 9:13 am • Updated: Oct 16, 2017, 9:41 am By Lenny Bernstein and Scott Higham, The Washington Post In April 2016, at the height of the deadliest drug epidemic in U.S. history, Congress effectively stripped the

CBD on the international stage: WHO committee delving into science, control status of cannabis compound

Published: Sep 20, 2017, 1:58 pm • Updated: Sep 20, 2017, 5:42 pm By Alicia Wallace, The Cannabist Staff Cannabidiol is a non-psychoactive cannabis compound touted for its medicinal promise — but marijuana- and hemp-derived extracts rich in CBD and

Skip to toolbar